STUDY OF NEUROVIRULENT PROPERTIES OF VACCINE AGAINST CULTURAL LIVE RUBELLA

STUDY OF NEUROVIRULENT PROPERTIES OF VACCINE AGAINST CULTURAL LIVE RUBELLA

Show other versions (1)

Experts at FSUE R&D Centre Microgen of the RF’s Healthcare Ministry have developed a national drug designed to prevent rubella — Cultural live vaccine against rubella on the basis of vaccinal strain RA 27/3. A pre-clinical study was conducted to examine neurovirulent properties of the seed v...

Full description

Bibliographic Details
Main Authors:	A.N. Mironov, A.A. Tsaan, D.S. Bushmenkov, A.A. Romanova, V.A. Merkulov, N.N. Stepanov
Format:	Article
Language:	English
Published:	Paediatrician Publishers, LLC 2010-07-01
Series:	Pediatričeskaâ Farmakologiâ
Online Access:	https://pf.spr-journal.ru/jour/article/view/1133

Similar Items

STUDY OF NEUROVIRULENT PROPERTIES OF VACCINE AGAINST CULTURAL LIVE RUBELLA
by: A.N. Mironov, et al.
Published: (2010-07-01)

CLINICAL STUDIES OF REACTOGENICITY, SAFETY AND IMMUNOGENICITY OF LIVE MONOVALENT INFLUENZA VACCINE (STRAIN А/17/CALIFORNIA/2009/38 — H1N1) IN CHILDREN
by: D.S. Bushmenkov, et al.
Published: (2010-07-01)

CLINICAL STUDIES OF REACTOGENICITY, SAFETY AND IMMUNOGENICITY OF LIVE MONOVALENT INFLUENZA VACCINE (STRAIN А/17/CALIFORNIA/2009/38 — H1N1) IN CHILDREN
by: D.S. Bushmenkov, et al.
Published: (2010-01-01)

Investigation of rubella vaccine maked MICROGEN Federal State Company: study I trial
by: A. N. Mironov, et al.
Published: (2011-02-01)

EVALUATION OF REACTOGENICITY, SAFETY AND IMMUNOGENICITY OF INACTIVATED MONOVALENT VACCINE IN CHILDREN
by: A.N. Mironov, et al.
Published: (2010-07-01)

EVALUATION OF REACTOGENICITY, SAFETY AND IMMUNOGENICITY OF INACTIVATED MONOVALENT VACCINE IN CHILDREN
by: A.N. Mironov, et al.
Published: (2010-01-01)

Live Viral Vaccine Neurovirulence Screening: Current and Future Models
by: Corey May Fulton, et al.
Published: (2021-06-01)

Using Real-Time RT-PCR Reagent Kits for Identity Testing of Measles, Mumps and Rubella Vaccines
by: A. S. Binyatova, et al.
Published: (2018-12-01)

Neurovirulent vaccine-derived polioviruses in sewage from highly immune populations.
by: Lester M Shulman, et al.
Published: (2006-01-01)

Rational use of rubella vaccine for prevention of congenital rubella syndrome in the Americas
by: Alan R. Hinman, et al.
Published: (1998-09-01)

A Case of Rubella Caused by Rubella Vaccination
by: Momoka Kamada, et al.
Published: (2021-09-01)

Development and study of the industrial reference standard for rubella vaccine activity
by: T. N. Yunasova, et al.
Published: (2018-02-01)

Microtitration of Rubella Virus in Monovalent Vaccinal Products
by: F Esna-Ashari, et al.
Published: (2011-03-01)

Microtitration of Rubella Virus in Monovalent Vaccinal Products
by: F Esna-Ashari, et al.
Published: (2011-03-01)

A Review on Rubella Vaccine: Iran (1975-2019)
by: A Shafayi, et al.
Published: (2021-06-01)

Molecular determinants of mumps virus neurovirulence
by: Lemon, Ken
Published: (2005)

Reações clínicas à vacinação de adultos contra a rubéola Clinical reactions against rubella vaccine in adults
by: J. A. N. Candeias, et al.
Published: (1980-03-01)

Differential host gene responses from infection with neurovirulent and partially-neurovirulent strains of Venezuelan equine encephalitis virus
by: Paridhi Gupta, et al.
Published: (2017-04-01)

INCIDENCE OF RUBELLA IN NORTH WEST RUSSIA ON THE STAGE OF ELIMINATION OF RUBELLA
by: M. A. Bichurina, et al.
Published: (2014-08-01)

Measles-Rubella vaccination campaign: A trust deficit?
by: A Sreedevi
Published: (2018-01-01)

A novel cancer vaccine for melanoma based on an approved vaccine against measles, mumps, and rubella
by: Aalto, K., et al.
Published: (2022)

Live, attenuated rubella vectors expressing HIV and SIV vaccine antigens
by: Berkower I, et al.
Published: (2012-09-01)

EVALUATION OF THREE RUBELLA VACCINES IN CONFERRING PROTECTION
by: K. Naficy, et al.
Published: (1974-09-01)

EVALUATION OF THREE RUBELLA VACCINES IN CONFERRING PROTECTION
by: K. Naficy, et al.
Published: (1974-09-01)

Antibody escape by polyomavirus capsid mutation facilitates neurovirulence
by: Matthew D Lauver, et al.
Published: (2020-09-01)

Studies on the genome structure of neurovirulent and attenuated polioviruses
by: Cann, Alan James
Published: (1984)

Functions of the Viral Attachment Protein in Reovirus Neurovirulence
by: Sutherland, Danica Marie
Published: (2019)

Rubella IgM epidemiology in the pre-rubella vaccination era in Uganda
by: Fred Bagenda, et al.
Published: (2020-03-01)

FEATURES OF POPULATION IMMUNITY AGAINST MEASLES AND RUBELLA VIRUSES. WHY DO ADULTS SUFFER?
by: M. A. Smerdova, et al.
Published: (2018-12-01)

Assessment of genetic changes and neurovirulence of shed Sabin and novel type 2 oral polio vaccine viruses
by: Rahnuma Wahid, et al.
Published: (2021-07-01)

Recombinant vesicular stomatitis virus vaccine vectors expressing filovirus glycoproteins lack neurovirulence in nonhuman primates.
by: Chad E Mire, et al.
Published: (2012-01-01)

Exploration of the neurovirulence of enterovirus 71 with mouse-adapted strains
by: Ya-Fang Wang, et al.
Published: (2007)

USING MUTAGENESIS AND STEM CELLS TO UNDERSTAND RETROVIRAL NEUROVIRULENCE
by: Renszel, Krystal Marie
Published: (2009)

A systematic review of rubella vaccination strategies : impact on rubella and CRS incidence
by: Chen, Bozhi, et al.
Published: (2014)

Seroepidemiology of rubella in students of Arak University of Medical Sciences,Three years after national vaccination program
by: A Ghazavi, et al.
Published: (2009-04-01)

The Impact of Rubella Vaccine Introduction on Rubella Infection and Congenital Rubella Syndrome: A Systematic Review of Mathematical Modelling Studies
by: Nkengafac Villyen Motaze, et al.
Published: (2021-01-01)

Mumps, Measles and Rubella Vaccination and Encephalitis
by: J Gordon Millichap
Published: (1989-09-01)

Shortening of Zika virus CD-loop reduces neurovirulence while preserving antigenicity.
by: Kenneth H Dinnon Iii, et al.
Published: (2019-03-01)

Dual miRNA targeting restricts host range and attenuates neurovirulence of flaviviruses.
by: Konstantin A Tsetsarkin, et al.
Published: (2015-04-01)

COMPARISON OF REACTOGENICITY AND IMMUNOGENICITY OF LIVE VACCINES AGAINST INFECTIOUS LARYNGOTRACHEITIS
by: S. A. Pokhvalny, et al.
Published: (2018-05-01)